Why a pharmaceutical revolution could quietly strengthen dairy’s place in the modern diet
There is a development reshaping food consumption that the dairy industry in the UK and Ireland has only just begun to notice. It is not coming from retail innovation, nor from the latest plant-based launch cycle. It is coming from medicine.
Over the past two years, GLP-1 weight-management therapies have moved from specialist diabetes treatments into mainstream public conversation. Drugs such as Ozempic and Wegovy are increasingly prescribed for weight management, and their impact on eating behaviour is significant.
The mechanism is well understood. These medications mimic the hormone glucagon-like peptide-1, slowing gastric emptying and signalling satiety earlier in the digestive process. People simply feel full sooner. As a result, they eat less.
Premium analysis
Keep reading with a free Briefing account
Briefing is free: up to three premium articles or reports a month, and the twice-monthly email briefing.
Want every premium article and report? Become a Member.
Premium analysis
You have read your three free pieces this month
Members read every premium article and report, with no monthly limit. Your free reads start again on the first of next month.
We could not open this article just now
Please try again in a moment. If it keeps happening, let us know.
Published by The Dairy Mail, Dairy Connect: https://www.dairy-connect.com/the-dairy-mail/glp-1-protein-and-dairys-moment-of-truth/
